greeksoup/ stock research
Stock research / United States / AKTS / Planned sales

Aktis Oncology, Inc. planned insider sales

In the last twelve months insiders at Aktis Oncology, Inc. filed 5 Form 144 notices of planned sales, 132,921 shares worth $3.5 million at the time of filing, from 4 sellers. The latest, filed 23 September 2026: Akos Czibere (officer), 25,000 shares worth $552,750, planned for around 23 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
23 September 2026Akos CzibereOfficer25,000$552,75023 September 202612,500 shares from 23 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
20 July 2026Ken HerrmannDirector4,856$119,27520 July 20264,856 shares from 20 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
17 July 2026Ken HerrmannDirector3,065$77,25917 July 20263,065 shares from 17 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
8 July 2026Shulamit Ron-BiggerOfficer50,000$1.4 million8 July 202650,000 shares from 8 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Options Under a Registered PlanForm 144
8 July 2026Akos CzibereOfficer50,000$1.4 million8 July 202650,000 shares from 8 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Options Under a Registered PlanForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?